Donna L. Snyder, MD, MBE

Food and Drug Administration
Silver Spring, Maryland

Donna L. Snyder, M.D. is the senior pediatric ethicist and team leader for the Ethics and International Team in the Office of Pediatric Therapeutics (OPT) in the Office of the Commissioner at the U.S. Food and Drug Administration (FDA). Dr. Snyder has worked at FDA since 2012, serving as a medical officer in the Division of Pediatric and Maternal Health within the Office of New Drugs before joining OPT in 2016. She currently serves on the FDA Pediatric Review Committee and on the FDA Institutional Review Board (IRB). Dr. Snyder received her MD from the University of Virginia, completed her internship and residency at the University of Maryland Hospital, her chief residency at Sinai Hospital in Baltimore, a Pediatric Academic Development Fellowship at Johns Hopkins Hospital and a Masters in Bioethics from the University of Pennsylvania. She is board certified in Pediatrics and a Fellow of the American Academy of Pediatrics. Dr. Snyder spent several years in pediatric private practice before pivoting to a career in research ethics. Just prior to joining the FDA, she worked as a research ethics consultant to an independent IRB and served as an IRB chair. She has also consulted for the NICHD IRB acting as the expedited reviewer for the National Children’s study.

Presentation(s):

• A05 - A Case Study Exploring the Ethical Considerations for Pediatric Clinical Trials

  Monday, December 12, 2022
  11:45 AM – 12:45 PM ET